Related Experiment Video
Updated: Jun 4, 2026
Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
PINK1/Parkin-based live-cell quantitative FRET imaging for mitophagy drug screening
Beini Sun1, Kangrong Deng1, Qialing Huang1
1MOE Key Laboratory of Laser Life Science & Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou, China.
Researchers developed a new method using Förster resonance energy transfer (FRET) imaging to screen drugs that promote mitophagy, the process of clearing damaged mitochondria. This method successfully identified four drugs that enhance the interaction between PTEN-induced kinase 1 (PINK1) and Parkin, key proteins in mitophagy.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- PTEN-induced kinase 1 (PINK1) and Parkin are crucial for maintaining mitochondrial homeostasis through mitophagy.
- Developing efficient drug screening methods for mitophagy is essential for understanding and treating mitochondrial dysfunction-related diseases.
Purpose of the Study:
- To establish and validate a quantitative Förster resonance energy transfer (FRET) imaging-based drug evaluation method for mitophagy.
- To assess the effect of five different drugs on the interaction between PINK1 and Parkin, key regulators of mitophagy.
Main Methods:
- Established a carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-induced mitophagy model in living cells.
- Utilized quantitative FRET imaging to measure the direct interaction between PINK1 and Parkin upon drug treatment.
- Verified mitophagy induction by assessing mitochondrial LC3 colocalization, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) levels.
Main Results:
- The CCCP-induced mitophagy model was successfully established and validated.
- CCCP, doxorubicin hydrochloride (DOX), metformin (Met), and resveratrol (RSV) significantly promoted the direct interaction between PINK1 and Parkin.
- 3-methyladenine (3-MA) did not promote the direct interaction between PINK1 and Parkin, indicating it does not activate this specific mitophagy pathway.
Conclusions:
- The PINK1/Parkin-based quantitative FRET imaging method is a viable tool for screening mitophagy-promoting drugs in living cells.
- This method can differentiate drugs that promote mitophagy by enhancing the PINK1-Parkin interaction.
